Spire Healthcare Group (LON:SPI) Reaches New 52-Week High at $267.06

Spire Healthcare Group plc (LON:SPI)’s stock price hit a new 52-week high on Wednesday . The company traded as high as GBX 267.06 ($3.39) and last traded at GBX 266.13 ($3.38), with a volume of 210451 shares traded. The stock had previously closed at GBX 258.50 ($3.29).

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SPI. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 344 ($4.37) price target on shares of Spire Healthcare Group in a research note on Thursday, April 18th. Berenberg Bank increased their price target on shares of Spire Healthcare Group from GBX 286 ($3.63) to GBX 300 ($3.81) and gave the stock a “buy” rating in a research note on Wednesday, April 17th.

Spire Healthcare Group Stock Performance

The company has a market cap of £1.08 billion, a PE ratio of 3,692.86, a P/E/G ratio of 1.06 and a beta of 0.97. The company has a debt-to-equity ratio of 170.37, a quick ratio of 0.74 and a current ratio of 0.69. The stock’s 50-day simple moving average is GBX 243.83 and its 200 day simple moving average is GBX 234.66.

Spire Healthcare Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, June 21st. Shareholders of record on Thursday, May 23rd will be given a dividend of GBX 2.10 ($0.03) per share. The ex-dividend date is Thursday, May 23rd. This represents a yield of 0.89%. This is an increase from Spire Healthcare Group’s previous dividend of $0.50. Spire Healthcare Group’s dividend payout ratio is presently 4,285.71%.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.